Changes Associated with the Entry of a Biosimilar in the Insulin Glargine Market

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{450ce7075eaf417688a40e6feb78950d,

title = "Changes Associated with the Entry of a Biosimilar in the Insulin Glargine Market",

author = "Joseph Levy and Chowdhury, {Zahra M.} and Socal, {Mariana P} and Trujillo, {Antonio J.}",

year = "2021",

doi = "10.1001/jamainternmed.2021.2769",

language = "English (US)",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Changes Associated with the Entry of a Biosimilar in the Insulin Glargine Market

AU - Levy, Joseph

AU - Chowdhury, Zahra M.

AU - Socal, Mariana P

AU - Trujillo, Antonio J.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85108895096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108895096&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2021.2769

DO - 10.1001/jamainternmed.2021.2769

M3 - Letter

C2 - 34180955

AN - SCOPUS:85108895096

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

ER -